1. Home
  2. MYND vs EGRX Comparison

MYND vs EGRX Comparison

Compare MYND & EGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • EGRX
  • Stock Information
  • Founded
  • MYND 1998
  • EGRX 2007
  • Country
  • MYND Cayman Islands
  • EGRX United States
  • Employees
  • MYND N/A
  • EGRX N/A
  • Industry
  • MYND Other Consumer Services
  • EGRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • EGRX Health Care
  • Exchange
  • MYND Nasdaq
  • EGRX Nasdaq
  • Market Cap
  • MYND 31.7M
  • EGRX 50.7M
  • IPO Year
  • MYND 2017
  • EGRX 2014
  • Fundamental
  • Price
  • MYND $0.80
  • EGRX $1.99
  • Analyst Decision
  • MYND
  • EGRX
  • Analyst Count
  • MYND 0
  • EGRX 0
  • Target Price
  • MYND N/A
  • EGRX N/A
  • AVG Volume (30 Days)
  • MYND 58.6K
  • EGRX 321.6K
  • Earning Date
  • MYND 11-03-2024
  • EGRX 11-12-2024
  • Dividend Yield
  • MYND N/A
  • EGRX N/A
  • EPS Growth
  • MYND N/A
  • EGRX N/A
  • EPS
  • MYND N/A
  • EGRX 0.91
  • Revenue
  • MYND $357,050,000.00
  • EGRX $257,551,000.00
  • Revenue This Year
  • MYND N/A
  • EGRX N/A
  • Revenue Next Year
  • MYND N/A
  • EGRX N/A
  • P/E Ratio
  • MYND N/A
  • EGRX $2.35
  • Revenue Growth
  • MYND N/A
  • EGRX N/A
  • 52 Week Low
  • MYND $0.61
  • EGRX $1.80
  • 52 Week High
  • MYND $14.20
  • EGRX $14.78
  • Technical
  • Relative Strength Index (RSI)
  • MYND 23.35
  • EGRX 19.60
  • Support Level
  • MYND $0.61
  • EGRX $1.80
  • Resistance Level
  • MYND $1.38
  • EGRX $4.11
  • Average True Range (ATR)
  • MYND 0.13
  • EGRX 0.40
  • MACD
  • MYND 0.01
  • EGRX -0.19
  • Stochastic Oscillator
  • MYND 27.84
  • EGRX 6.86

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

About EGRX Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

Share on Social Networks: